Sintx Technologies, Inc. — Director's Dealing 2014

Feb 21, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMEDICA Corp (AMDA)
CIK: 0001269026
Period of Report: 2014-02-19

Reporting Person: Kipke Arthur Karl (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-19	Common Stock	C	16914	—	Acquired	16914	Indirect
2014-02-19	Common Stock	C	115656	—	Acquired	115656	Indirect
2014-02-19	Common Stock	C	25915	—	Acquired	25915	Indirect
2014-02-19	Common Stock	C	1250000	—	Acquired	1303347	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-19	Series D Preferred Stock	$	C	335100	Disposed		Common Stock (16914)	Indirect
2014-02-19	Series D Preferred Stock	$	C	2290600	Disposed		Common Stock (115656)	Indirect
2014-02-19	Series D-1 Preferred Stock	$	C	181000	Disposed		Common Stock (11828)	Indirect
2014-02-19	Series E Preferred Stock	$	C	319542	Disposed		Common Stock (14087)	Indirect
2014-02-19	Series F Preferred Stock	$	C	5000000	Disposed		Common Stock (1250000)	Indirect

Footnotes

F1: Each share of Series D Convertible Preferred Stock converted into 1.3014 shares of the Issuer's Common Stock pursuant to the terms of the Certificate of Designation for Series D Convertible Preferred Stock of the Issuer and had no expiration date.

F2: Each share of Series D-1 Convertible Preferred Stock converted into 1.6834 shares of the Issuer's Common Stock pursuant to the terms of the Certificate of Designation for Series D-1 Convertible Preferred Stock of the Issuer and had no expiration date.

F3: Each share of Series E Convertible Preferred Stock converted into 1.1363 shares of the Issuer's Common Stock pursuant to the terms of the Certificate of Designation for Series E Convertible Preferred Stock of the Issuer and had no expiration date.

F4: Each share of Series F Convertible Preferred Stock converted into 6.44370 shares of the Issuer's Common Stock pursuant to the terms of the Certificate of Designation for Series F Convertible Preferred Stock of the Issuer and had no expiration date.

F5: Reflects a 1-for-25.7746 reverse split of the Issuer's common stock effected on February 11, 2014.

F6: Shares held by Hampshire Asset Managements, LLC, of which the Reporting Person is the presdent. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein.

F7: Shares held by KM Healthcare Holdings LP. The Reporting Person shares voting and dispositive power with the general partner of KM Healthcare Holdings LP. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein.

F8: Shares held by Hampshire Healthcare Partners LP, of which the Reporting Person is the managing member of the general partner, Hampshire Special Opportunities, LLC. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein.

F9: Shares held by Hampshire Med Tech Partners, LP, of which the Reporting Person is the managing member of the general partner, Hampshire Med Tech Partners GP, LLC. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein.